ORNYX OÜ
- Registry code
- 14871537
- VAT number
- EE102308558
- Address
- Ida-Viru maakond, Jõhvi vald, Edise küla, Aiandi keskus 7, 41558
- Registered
- 18.12.2019 · 6 yrs
- Activity
- Wholesale of pharmaceutical goods 46461
- Capital
- 2 500 €
- s•••@g•••.comLog in to see
- Phone
- +49 1515•• ••••Log in to see
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2024)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
2 persons
| Board 2 | ||
|---|---|---|
| Artur Savin1 companyno tax debt | Personal ID ↗ | 20.09.2021 |
| Irina Nikitina2 companiesno tax debt | Personal ID ↗ | 22.06.2023 |
| Shareholders 2 | ||
| Artur Savin | 60,0% 1 500 € | 01.09.2023 |
| Irina Nikitina | 40,0% 1 000 € | 01.09.2023 |
| Beneficial owners 2 | ||
| Artur Savin1 companyno tax debtkõrgema juhtorgani liige. s.o juhatuse liige või nõukogu liige | 15.09.2023 | |
| Irina Nikitina2 companiesno tax debtkõrgema juhtorgani liige. s.o juhatuse liige või nõukogu liige | 15.09.2023 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 2 496 165 € | ▲ 1409% | 142 512 € | 147 076 € | 9 |
| 2026 Q1 | 3 807 756 € | ▲ 2615% | 144 583 € | 147 090 € | 10 |
| 2025 Q4 | 1 453 818 € | ▲ 611% | 101 764 € | 128 156 € | 9 |
| 2025 Q3 | 910 844 € | ▲ 818% | 92 700 € | 173 511 € | 9 |
| 2025 Q2 | 165 469 € | ▲ 22% | 76 796 € | 131 308 € | 8 |
| 2025 Q1 | 140 256 € | ▲ 36% | 79 377 € | 92 949 € | 8 |
| 2024 Q4 | 204 503 € | ▲ 112% | 64 860 € | 74 614 € | 9 |
| 2024 Q3 | 99 225 € | ▼ 17% | 96 351 € | 166 541 € | 8 |
| 2024 Q2 | 135 221 € | ▼ 28% | 56 547 € | 57 985 € | 8 |
| 2024 Q1 | 103 094 € | ▲ 200% | 72 406 € | 105 323 € | 9 |
| 2023 Q4 | 96 400 € | ▲ 60% | 50 421 € | 169 001 € | 8 |
| 2023 Q3 | 119 079 € | ▲ 508% | 30 685 € | 122 626 € | 7 |
Näita kogu ajalugu (18 kvartalit)
| 2023 Q2 | 188 280 € | ▲ 927% | 22 740 € | 22 442 € | 2 |
| 2023 Q1 | 34 368 € | ▼ 74% | 28 210 € | 130 724 € | 2 |
| 2022 Q4 | 60 069 € | 15 004 € | 134 870 € | 2 | |
| 2022 Q3 | 19 577 € | 13 604 € | 13 531 € | 2 | |
| 2022 Q2 | 18 331 € | 13 604 € | 13 531 € | 1 | |
| 2022 Q1 | 130 207 € | 6 979 € | 6 910 € | 1 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | 5,1 m € | ▼ 13% | 5,9 m € | ▼ 5% | 6,2 m € | ▲ 228% | 1,9 m € |
| Profit | 1,2 m € | ▼ 36% | 1,8 m € | ▼ 47% | 3,5 m € | ▲ 258% | 972 k € |
| Profit margin | 23,1% | 31,6% | 56,5% | 51,7% | |||
| Jaotamata kasum | 2,7 m € | ▲ 220% | 832 k € | ▲ plussi | -19 774 € | ▲ 28% | -27 481 € |
| Cash | 106 k € | ▲ 242% | 31 049 € | ▼ 89% | 285 k € | ▲ 38× | 7 423 € |
| Current assets | 4,6 m € | ▲ 11% | 4,1 m € | ▲ 11% | 3,7 m € | ▲ 141% | 1,5 m € |
| Põhivara | 1,0 m € | ▲ 14% | 893 k € | ▲ 122% | 403 k € | — | |
| Assets | 5,6 m € | ▲ 11% | 5,0 m € | ▲ 22% | 4,1 m € | ▲ 167% | 1,5 m € |
| Current liabilities | 1,8 m € | ▼ 25% | 2,3 m € | ▲ 253% | 666 k € | ▲ 132% | 286 k € |
| Pikaajalised kohustised | 0 € | 0 € | 0 € | ▼ 100% | 312 k € | ||
| Total liabilities | 1,8 m € | ▼ 25% | 2,3 m € | ▲ 253% | 666 k € | ▲ 11% | 599 k € |
| Equity | 3,8 m € | ▲ 43% | 2,7 m € | ▼ 23% | 3,5 m € | ▲ 266% | 947 k € |
| Tööjõukulud | -614 k € | ▼ 66% | -369 k € | ▼ 165% | -139 k € | ▼ 142% | -57 751 € |
| Employees | 11 | ▲ 10% | 10 | ▲ 150% | 4 | ▲ 33% | 3 |
| Filed | 06.10.2025 | 17.05.2024 | 21.06.2023 | 31.08.2022 | |||
| Report | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ | In the Business Register ↗ |
▲ kasv, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2024
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Wholesale of pharmaceutical goods main activity | 46461 | 5 107 162 € | 100% |
2024 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
1
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Wholesale of pharmaceutical goods
20
| # | Company | Revenue |
|---|---|---|
| 1 | MAGNUM MEDICAL OÜ | 295,0 m € |
| 2 | TAMRO EESTI OÜ | 239,6 m € |
| 3 | Novo Nordisk Estonia OÜ | 37,0 m € |
| 4 | SONA-PHARM OÜ | 36,9 m € |
| 5 | Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal | 30,7 m € |
| 6 | Aktsiaselts Magnum Veterinaaria | 28,6 m € |
| 7 | Osaühing Zoovetvaru | 21,5 m € |
| 8 | Osaühing Berlin-Chemie Menarini Eesti | 17,3 m € |
| 9 | Globalex Pharma OÜ | 16,1 m € |
| 10 | OÜ Micotrade | 15,8 m € |
| 11 | Apteegikaubanduse Hulgimüük OÜ | 12,2 m € |
| 12 | Aktsiaselts FORANS EESTI | 8,0 m € |
| 13 | DAAAK Pharma Int. AS | 7,6 m € |
| 14 | Gerdavit OÜ | 7,2 m € |
| 15 | AS Oribalt Tallinn | 7,0 m € |
| 16 | Aktsiaselts PAIRA | 6,2 m € |
| 17 | ORNYX OÜ | 5,1 m € |
| 18 | Pharm Origin OÜ | 5,1 m € |
| 19 | First Pharma OÜ | 4,9 m € |
| 20 | Hiirehernes OÜ | 4,8 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
11
| Date | Liik | Sisu |
|---|---|---|
| 24.11.2023 | Kanne | Muutmiskanne |
| 26.10.2023 | Kanne | Muutmiskanne |
| 18.09.2023 | Kanne | Muutmiskanne TsMS § 595¹ lg 1 alusel |
| 01.09.2023 | Kanne | Muutmiskanne |
| 22.06.2023 | Kanne | Muutmiskanne |
| 03.05.2023 | Kanne | Muutmiskanne |
| 01.10.2021 | Korraldav määrus | |
| 20.09.2021 | Kanne | Muutmiskanne |
| 10.05.2021 | Kanne | Muutmiskanne |
| 18.12.2019 | Kanne | Esmakanne |
| 11.12.2019 | Puuduste kõrvaldamise määrus | Esmakanne |